Nnit A/s · OMXCOP:NNIT
Nnit A/s — ABG Sundal Collier IT seminar, Copenhagen (April 2015)
17 slides from Nnit A/s's conference presentation, Apr 16, 2015
Slide 1: NNIT
NNIT ABG Sundal Collier 16 April 2015
Slide 2: Disclaimer
Disclaimer This presentation has been prepared and issued by, and is the sole responsibility of, NNIT A/S (“NNIT” and, together with its subsidiaries, the “Group”). For the purposes of this notice, the presentation that follows (the “Presentation”) shall mean and include the slides that follow, the
Slide 3: Leveraging our Novo Nordisk Heritage and Differentiated Compliance DNA to Win Profitable Market Shares
Leveraging our Novo Nordisk Heritage and Differentiated Compliance DNA to Win Profitable Market Shares Danish IT Market Leader Top 3 Leading market share in IT services market in Denmark and Fastest Growing Player (1) Global Delivery Model Market Share Winner with Historical Organic Revenue Growth 3
Slide 4: Great Track Record of Profitable Growth while Diversifying Our Revenue Base
Great Track Record of Profitable Growth while Diversifying Our Revenue Base Revenue Mix Development Since 2004 Novo Nordisk vs. non-Novo Nordisk DKKm Non-Novo Nordisk Revenue 10th consecutive New Novo Nordisk Revenue year with double Data Per Kogut – digit growth centre 2,410 Operating Margin (%) ne
Slide 5: Leveraging Our Compliance DNA Drives Diversification
Leveraging Our Compliance DNA Drives Diversification Our Core Leveraging Our Compliance DNA Life Public Finance Enterprise Sciences DKK 1,547m DKK 326m DKK 166m DKK 371m (64%) (14%) (7%) (15%) See Note (1) DKK 743m (31%) IT Solutions Services: Advisory services, business solutions and application ma
Slide 6: We Have a Track Record of Strong Organic Growth Over the Years
We Have a Track Record of Strong Organic Growth Over the Years Long Track Record of Resilient Organic Growth, above GDP We Have Delivered According to Our Long- and Peers (1) Term Historical Operating Targets DKKm Realised vs. Target +12% +11% +14% +15% +20% +14% +4% +9% +13% +9% +9% 2,410 Realised
Slide 7: Novo Nordisk Connection to NNIT
Novo Nordisk Connection to NNIT Long Track Record of Resilient Growth of Novo Novo Nordisk Relationship Nordisk Revenues DKKm Novo Nordisk’s strategic IT partner − NNIT has developed highly complex mission-critical solutions for Novo Nordisk 1,260 − NNIT operates Novo Nordisk’s strategic systems 1
Slide 8: Our Growing Backlog Provides Strong Visibility
Our Growing Backlog Provides Strong Visibility High visibility supported by more than 70% of annual sales covered by the backlog (1) at beginning of the year NNIT’s Order Backlog DKKm As % of Following Year’s Revenue Backlog for year 1 Backlog for years 2 and 3 +10% +6% +14% +13% 74.5 74.8 2,533 2,2
Slide 9: 2020 Strategy
The Key Pillars of Our Growth Strategy 1 Increase our share of existing customers’ IT spending 2 In Denmark Win new customers 2020 Strategy 3 Support Danish customers with their internationalisation Win Profitable Market Share 4 Internationally Life Sciences Supporting Pillars 5 Continue our cost e
Slide 10: Leading Market Share in Danish IT Services Market
Leading Market Share in Danish IT Services Market Danish IT Services Market Development vs. NNIT Danish IT Services Market (2013 Revenue (1)) DKKm +x% 2012-2013 YoY Growth 7,000 (3%) 6,000 5,748 5,000 (0%) 3,956 4,000 +10% 3,000 (10%) 2,116 +1% (2%) 2,000 +2% (1%) 1,477 +7% 1,266 1,140 (7%) 1,066 1,
Slide 11: With Space to Grow Further As The Leading Local Provider
…With Space to Grow Further As The Leading Local Provider – As Seen In Other European Countries 2013 Market Share of Leading Local IT Services Providers in Their Country of Origin % market share and ranking Norway Sweden Denmark 1st 1st Finland 24% 9% 3rd 1st 6% 19% France Germany 1st 1st 9% 9% Spai
Slide 12: We Have a Strong Expertise in Life Sciences…
We Have a Strong Expertise in Life Sciences… NNIT Delivers Value Added Solutions to Well- …. Thanks to Leading-Edge Solutions Tailored to Life Recognized Pharmaceutical Groups… Sciences Largest Pharmaceutical Companies by Market Capitalisation €bn Unique, in-depth familiarity with Johnson & proces
Slide 13: … And a Deep Array of Differentiated Solutions
3 … And a Deep Array of Differentiated Solutions Integrated Drug Integrated Drug Integrated Integrated Supply Development Regulatory Affairs Quality Chain Management • Clinical Information • Regulatory • Compliance • Strategic Planning Strategy Management Information Assessments • Manufacturing & SC
Slide 14: … and Life Sciences Represent an Attractive Upside Opportunity
… and Life Sciences Represent an Attractive Upside Opportunity We are a leader in the Danish life sciences IT services market and have opportunities to grow internationally NNIT is Well Positioned in a Growing International Life Sciences Target Market (1) Western Europe (excl. Denmark) + US 2014 202
Slide 15: …Via Continued Focus on Cost Efficiency…
…Via Continued Focus on Cost Efficiency… % of employees based in low cost locations (1) Employee cost per FTE (rebased to 100 in 2012) 25% 30% 34% 100 95 93 2012 2013 2014 2012 2013 2014 COGS Other Offshore / Nearshore At group level, overall employee cost per FTE declined from 100 basis in 2012 t
Slide 16: Guidance / Outlook Statement
Guidance / Outlook Statement Revenue growth 5-8% at constant currencies(1) Around 0.6pp higher as reported (2) 2015 Operating margin Around 11% at constant currencies(1) Around 1.2pp lower as reported (2) Target average growth in revenue of at least 5% in constant currencies Long Term
Slide 17: Segmental Breakdown of Guidance
Segmental Breakdown of Guidance Segmental guidance should be seen as a guidance over time and not for individual years. This is due to the size of our segments where addition or loss of a single large contract can result in very volatile developments Segmental Novo Int’l Life Public Finance Enterpri
Nnit — ABG Sundal Collier IT seminar, Copenhagen (April 2015) on 6ix